IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential
Björn P. Johansson, Oonagh Shannon, Lars Björck · 2008
Read IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential by Björn P. Johansson, Oonagh Shannon, Lars Björck (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001692.txt.
Description
Björn P. Johansson, Oonagh Shannon, and Lars Björck reviewed a bacterial enzyme with drug potential in a 2008 PLOS ONE research article. The enzyme is IdeS, made by Streptococcus pyogenes, a common cause of strep throat. IdeS cuts IgG antibodies with unusual precision, snipping one bond and disabling the antibody.
Harmful IgG antibodies drive several autoimmune diseases and can cause acute transplant rejection. An enzyme that removes them cleanly could become a treatment. The full text covers how IdeS works, its specificity, and the medical settings where it might help. Turning a bacterium's weapon against the immune system into a tool for calming that same system is the paper's central, elegant idea.
Catalog record
| CREATOR | Björn P. Johansson, Oonagh Shannon, Lars Björck |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001692